140 related articles for article (PubMed ID: 11872096)
1. Immunization onto bare skin with synthetic peptides: immunomodulation with a CpG-containing oligodeoxynucleotide and effective priming of influenza virus-specific CD4+ T cells.
Beignon AS; Briand JP; Muller S; Partidos CD
Immunology; 2002 Feb; 105(2):204-12. PubMed ID: 11872096
[TBL] [Abstract][Full Text] [Related]
2. Immunization onto bare skin with heat-labile enterotoxin of Escherichia coli enhances immune responses to coadministered protein and peptide antigens and protects mice against lethal toxin challenge.
Beignon AS; Briand JP; Muller S; Partidos CD
Immunology; 2001 Mar; 102(3):344-51. PubMed ID: 11298834
[TBL] [Abstract][Full Text] [Related]
3. The pulmonary environment promotes Th2 cell responses after nasal-pulmonary immunization with antigen alone, but Th1 responses are induced during instances of intense immune stimulation.
Jones HP; Hodge LM; Fujihashi K; Kiyono H; McGhee JR; Simecka JW
J Immunol; 2001 Oct; 167(8):4518-26. PubMed ID: 11591779
[TBL] [Abstract][Full Text] [Related]
4. Immunization of aged mice with a pneumococcal conjugate vaccine combined with an unmethylated CpG-containing oligodeoxynucleotide restores defective immunoglobulin G antipolysaccharide responses and specific CD4+-T-cell priming to young adult levels.
Sen G; Chen Q; Snapper CM
Infect Immun; 2006 Apr; 74(4):2177-86. PubMed ID: 16552048
[TBL] [Abstract][Full Text] [Related]
5. Breaking immune tolerance to the prion protein using prion protein peptides plus oligodeoxynucleotide-CpG in mice.
Rosset MB; Ballerini C; Gregoire S; Metharom P; Carnaud C; Aucouturier P
J Immunol; 2004 May; 172(9):5168-74. PubMed ID: 15100253
[TBL] [Abstract][Full Text] [Related]
6. The LTR72 mutant of heat-labile enterotoxin of Escherichia coli enhances the ability of peptide antigens to elicit CD4(+) T cells and secrete gamma interferon after coapplication onto bare skin.
Beignon AS; Briand JP; Rappuoli R; Muller S; Partidos CD
Infect Immun; 2002 Jun; 70(6):3012-9. PubMed ID: 12010992
[TBL] [Abstract][Full Text] [Related]
7. The adjuvant effect of CpG oligodeoxynucleotide linked to the non-toxic B subunit of cholera toxin for induction of immunity against H. pylori in mice.
Nyström-Asklin J; Adamsson J; Harandi AM
Scand J Immunol; 2008 May; 67(5):431-40. PubMed ID: 18298617
[TBL] [Abstract][Full Text] [Related]
8. Serum and mucosal immune responses to an inactivated influenza virus vaccine induced by epidermal powder immunization.
Chen D; Periwal SB; Larrivee K; Zuleger C; Erickson CA; Endres RL; Payne LG
J Virol; 2001 Sep; 75(17):7956-65. PubMed ID: 11483740
[TBL] [Abstract][Full Text] [Related]
9. Helper T cell subsets for immunoglobulin A responses: oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa associated tissues.
Xu-Amano J; Kiyono H; Jackson RJ; Staats HF; Fujihashi K; Burrows PD; Elson CO; Pillai S; McGhee JR
J Exp Med; 1993 Oct; 178(4):1309-20. PubMed ID: 8376936
[TBL] [Abstract][Full Text] [Related]
10. Plasmid DNA encoding influenza virus haemagglutinin induces Th1 cells and protection against respiratory infection despite its limited ability to generate antibody responses.
Johnson PA; Conway MA; Daly J; Nicolson C; Robertson J; Mills KH
J Gen Virol; 2000 Jul; 81(Pt 7):1737-45. PubMed ID: 10859379
[TBL] [Abstract][Full Text] [Related]
11. Determination of cytokine co-expression in individual splenic CD4+ and CD8+ T cells from influenza virus-immune mice.
Falchetti R; Di Francesco P; Lanzilli G; Gaziano R; Casalinuovo IA; Palamara AT; Ravagnan G; Garaci E
Immunology; 1998 Nov; 95(3):346-51. PubMed ID: 9824496
[TBL] [Abstract][Full Text] [Related]
12. Transcutaneous immunization in auricle skin induces antigen-specific mucosal and systemic immune responses in BALB/c mice.
Nagano H; Jimura T; Nagano M; Makise T; Miyashita K; Kurono Y
Auris Nasus Larynx; 2017 Aug; 44(4):411-416. PubMed ID: 27637556
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity of a contiguous T-B synthetic epitope of the A/PR/8/34 influenza virus.
Brumeanu TD; Casares S; Bot A; Bot S; Bona CA
J Virol; 1997 Jul; 71(7):5473-80. PubMed ID: 9188620
[TBL] [Abstract][Full Text] [Related]
14. Oral Immunization with a Multivalent Epitope-Based Vaccine, Based on NAP, Urease, HSP60, and HpaA, Provides Therapeutic Effect on
Guo L; Yang H; Tang F; Yin R; Liu H; Gong X; Wei J; Zhang Y; Xu G; Liu K
Front Cell Infect Microbiol; 2017; 7():349. PubMed ID: 28824883
[TBL] [Abstract][Full Text] [Related]
15. In vivo priming of CD4 T cells that produce interleukin (IL)-2 but not IL-4 or interferon (IFN)-gamma, and can subsequently differentiate into IL-4- or IFN-gamma-secreting cells.
Wang X; Mosmann T
J Exp Med; 2001 Oct; 194(8):1069-80. PubMed ID: 11602637
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the Immunogenicity of a Potyvirus-Like Particle as an Adjuvant of a Synthetic Peptide.
Cárdenas-Vargas A; Elizondo-Quiroga D; Gutierrez-Ortega A; Charles-Niño C; Pedroza-Roldán C
Viral Immunol; 2016 Dec; 29(10):557-564. PubMed ID: 27834623
[TBL] [Abstract][Full Text] [Related]
17. Intranasal administration of adjuvant-combined recombinant influenza virus HA vaccine protects mice from the lethal H5N1 virus infection.
Asahi-Ozaki Y; Itamura S; Ichinohe T; Strong P; Tamura S; Takahashi H; Sawa H; Moriyama M; Tashiro M; Sata T; Kurata T; Hasegawa H
Microbes Infect; 2006 Oct; 8(12-13):2706-14. PubMed ID: 16968669
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of mucosal immunization with virus-like particles of simian immunodeficiency virus.
Kang SM; Compans RW
J Virol; 2003 Mar; 77(6):3615-23. PubMed ID: 12610137
[TBL] [Abstract][Full Text] [Related]
19. Effects of MF59 Adjuvant on Induction of Isotype-Switched IgG Antibodies and Protection after Immunization with T-Dependent Influenza Virus Vaccine in the Absence of CD4+ T Cells.
Ko EJ; Lee YT; Kim KH; Jung YJ; Lee Y; Denning TL; Kang SM
J Virol; 2016 Aug; 90(15):6976-6988. PubMed ID: 27226368
[TBL] [Abstract][Full Text] [Related]
20. Modulation of memory CD4 T cell function and survival potential by altering the strength of the recall stimulus.
Patke DS; Farber DL
J Immunol; 2005 May; 174(9):5433-43. PubMed ID: 15843542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
